Prof. Radha K. Dhiman is currently the Director and Professor and Head Department of Hepatology and Director of the Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow. Throughout his career, he has remained in many important positions including his stint as Director, Kalyan Singh Super-Specialty Cancer institute, Lucknow, Chairman, National Action Plan for Viral Hepatitis, Govt. of India, Member, National Medical Commission, Member, National Academy of Medical Sciences, India, and Editor-in-Chief, Journal of Clinical & Experimental Hepatology (JCEH). He also served as the President (2014-2017) of the International Society on Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN). He has been awarded the prestigious Dr. BC Roy National Award; Highest Award in the medical field. Received from Honorable President of India Smt Pratibha Devisingh Patil on July 2, 2008, Harold O Conn award by American Association for the study of Liver (AASLD) at the Annual Meeting held in November, Boston, USA, and several awards from the ICMR, India including “Basanti Devi Amir Chand” by ICMR for the year 2009 for outstanding contribution in Hepatology, “Amrut Modi Unichem” given by ICMR in 2007 for significant contribution in Portal hypertension, “Shakuntala Amir Chand Award” given by ICMR for “Prognostic evaluation of early indicators in fulminant hepatic failure by multivariate analysis” in 1998, and “Dr DV Datta Memorial Oration Award” for excellence in research in Liver Diseases in 1996. His area of interest in clinical and basic has been i) Hepatic encephalopathy, ii) Liver transplantation and iii) Viral hepatitis C. He created a brain bank at PGIMER, Chandigarh for basic research in liver diseases. His research in both basic and clinical areas related to various aspects of hepatic encephalopathy, including minimal and overt hepatic encephalopathy, acute liver failure, and acute on chronic liver failure, is well recognized nationally and internationally. Dr. Dhiman is currently working towards the Elimination of Viral Hepatitis from India. Viral hepatitis is a leading cause of death in the world, which is comparable to that of HIV, tuberculosis, and malaria.
Mohammad Shadab Siddiqui, MD is currently Associate Professor of Medicine at Virginia Commonwealth University in the Division of Gastroenterology and Hepatology. His clinical and research interest are largely in nonalcoholic fatty liver disease (NAFLD). More specifically, he is interested in the liver-heart axis and metabolic complications of NAFLD. This research spans a full spectrum of NAFLD that includes early disease, cirrhosis, and post-LT NAFLD. He also has an interest in biomarker development and regulatory science. In his publications, he has demonstrated the impact that NAFLD has on lipoprotein metabolism and the clinical implications of this impact. His work in the cirrhosis cohort has attempted to better define cardiovascular risk assessment prior to liver transplantation. Furthermore, his publications have also provided additional insight on CVD after LT.
Dr. Puri is a graduate of Sawai Man Singh Medical College where he also completed his internal medicine residency. Following his residency training at the University of Massachusetts affiliated St Vincent hospital, he completed the T32 NIH fellowship at the Virginia Commonwealth University where he joined as a faculty. He is an Associate Professor at VCU with clinical operations at Central Virginia Veterans Affairs System where he oversees the metabolic liver disease program. He expertises in metabolic and alcohol-related fatty liver disease and clinical nutrition in liver disease. His research interest focus on Metabolomics and microbiome interactions, lifestyle medicine including clinical nutrition, and clinical models of care with a special focus on the Veterans.
Aftab Ala is Professor of Hepatology at Institute of Liver Studies at Kings College Hospital, London and University of Surrey, Guildford. He is National Institute of Health Research (NIHR) Director for South East England and Professional Director for Research and Development. He leads the adult genetic metabolic liver programme at Kings College Hospital
He qualified from Imperial College Medical School London in 1992, trained in specialist Gastroenterology and Hepatology at King's and Royal Free Hospitals London, before being appointed to Division of Liver Diseases and Recanti Miller Transplantation Institute, Mount Sinai Hospital New York, USA in 2003-4 with a focus on liver transplantation and rare genetic metabolic liver diseases.
He is Principal and Chief investigator in national and multi-center international clinical trials and research related to liver disease including genetic metabolic liver disease and inequalities of health. His research is funded by the NIHR and Medical Research Council clinical research fellows on the MD/PhD Research Programme at Kings College Hospital and the University of Surrey with established international collaborative links.
Dr. Singal is a Professor of Medicine at the University of South Dakota Sanford School of Medicine and a Transplant Hepatologist at the Avera TransplantInstitute.
Prof Lopa Mishra is currently a Professor of Medicine at the Feinstein Institutes for Medical Research and Cold Spring Harbor Laboratory, and Merinoff Endowed Chair, and Co-Director, The Institute for Bioelectronic Medicine. She is also an attending physician at the Divisions of Gastroenterology and Hepatology, Northwell Health, USA. The current talk was presented at the INEDSYS Hepatology Club Bi-Monthly meeting on October 02, 2021. Dr. Mishra has extensively reviewed the state of the current biomarkers in hepatocellular carcinoma.
Prof. Prasun Jalal, MD Stan and Sue Partee Professor of Hepatology, Baylor College of Medicine, Houston, Texas, USA
Dr. Abha Nagral, MD, is a consultant at the Apollo Hospital Navi Mumbai and Jaslok Hospitals, Mumbai